Log In
BCIQ
Print this Print this
 

HYC750

  Manage Alerts
Collapse Summary General Information
Company Orcrist Bio Inc.
DescriptionHyaluronic acid formulation
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentPhase I
Standard IndicationNeutropenia
Indication DetailsTreat chemotherapy-induced neutropenia (CIN)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today